REFRACTORY METASTATIC COLORECTAL CANCER
Clinical trials for REFRACTORY METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for REFRACTORY METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat colon cancer: major trial tests promising drug combo
Disease control Recruiting nowThis study is testing whether adding a new drug called Suvemcitug to a standard chemotherapy pill works better than the pill alone for people with advanced colorectal cancer that has stopped responding to other treatments. About 464 participants will be randomly assigned to recei…
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New Liver-Targeted attack on stubborn colon cancer
Disease control Recruiting nowThis study is for people with advanced colorectal cancer that has spread mainly to the liver and is no longer responding to standard treatments. It aims to see if a procedure that delivers high-dose chemotherapy directly to the liver, followed by standard oral cancer drugs, works…
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC